Dr Reddy’s Laboratories: Global pharmaceutical company, India

  Quick Links
   Company News Coverage
   Sustainability Report
   NCE Pipeline
   Our Values
 
Get it here
             first-hand
  Press Releases

Subscriptions: Want to stay updated? Click here to subscribe to our press releases
Dec | Nov | Oct | Sep | Aug | Jul | Jun | May | Apr | Feb  | Jan
 
Dr Reddy's Q1 net profit rises 115% to Rs.535 million
July 31, 2001
Dr Reddy's anticipates to launch fluoxetine 40mg capsules on August 3, 2001
July 31, 2001
Dr Reddy's to release first quarter results July 31, 2001
July 30, 2001
Dr Reddy's Laboratories-American Remedies merger completed
July 23, 2001
Novartis and Novo Nordisk partners for commercialization of Dr Reddy's compound DRF 2725 (NN622) in North America.
July 19, 2001
Novartis and Novo Nordisk partners for commercialization of Dr Reddy's compound DRF 2725 (NN622) in North America.
July 19, 2001

The information contained in the releases was current on the date they were issued and will become or may have become outdated over time. Dr. Reddy's does not assume any responsibility for updating
information in the releases.

  Triple Bottom Line
  Download Brochures
  Key Milestones
   
Designed by
© 2001 - 2008 Dr. Reddy's Laboratories Ltd. All rights reserved
Site best viewed at 800x600 resolution